Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Published on by Oncology

Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Shandong Second Medical University | China

Author Profile

Scopus

๐ŸŒŸ Dr. Lv Huaiqing, M.D.

Chief Physician & Masterโ€™s Degree Supervisor

Director of Otorhinolaryngology & Head and Neck Surgery

Linyi People’s Hospital, Shandong Province

๐Ÿ‘ฉโ€โš•๏ธ Professional Summary:

Dr. Lv Huaiqing is a distinguished Chief Physician and subject leader at Linyi People’s Hospital, specializing in Otorhinolaryngology and Head and Neck Surgery. With extensive experience in clinical practice and research, Dr. Lv has significantly contributed to the field through her leadership roles and numerous scientific projects.

**๐ŸŒ Part-Time Roles:

  • Vice Chairman, Otorhinolaryngology, Head and Neck Surgery Committee, Shandong Provincial Medical Association
  • Vice Chairman, Hearing and Balance Medical Association, Shandong Provincial Medical Association
  • Member, Voice Committee, Otorhinolaryngology Committee, Chinese Association of Integrative Medicine
  • Standing Member, Head and Neck Tumor Committee, China Medical Education Association
  • Vice Chairman, Ear, Nose and Throat Committee, Shandong Association of Integrative Medicine
  • Vice Chairman, Pharyngeal, Head and Neck Surgery Committee, Shandong Provincial Association of Health Management
  • Director, Linyi Otorhinolaryngology Quality Control Center
  • Linyi Health Leader
  • Director, Otolaryngology Branch, Linyi Physicians Association

๐Ÿ“š Research Contributions:

Dr. Lv has authored 13 papers as the first author or corresponding author in the past year. She has presided over 3 provincial and municipal level projects, including:

  • Application of Posterior Auricular Groove Incision in Surgery of Benign Tumor of Parotid Gland
  • Evaluation of Orbital Invasion of Sinus Tumor Based on CT, MRI, and Machine Learning Models
  • Posterior Auricular Groove Incision in Surgery of Benign Tumor of Superficial Parotid Gland

Her research has received significant funding of 400,000 RMB and has led to several municipal science and technology awards. The research team excels in various methods, including bioinformatics, meta-analysis, and machine learning predictive models.

๐ŸŽ“ Teaching Commitment:

Currently, Dr. Lv supervises Masterโ€™s degree students at Qingdao University, Shandong Second Medical University, and Binzhou Medical College, having guided 10 students to date.

๐Ÿ”ฌ Current Publications:

She is also the first author or corresponding author of approximately 20 newly accepted and submitted articles in Chinese core or SCI journals.

Dr. Lv Huaiqingโ€™s dedication to otorhinolaryngology, combined with her commitment to research and education, makes her a leading figure in her field.

๐Ÿ”” Conclusion

Dr. Lv Huaiqing stands out as a prominent leader in Otorhinolaryngology and Head and Neck Surgery, with a rich background in clinical practice, research, and education. Her extensive involvement in various medical associations and committees demonstrates her commitment to advancing the field and enhancing patient care. Through her innovative research projects and dedication to mentoring future healthcare professionals, Dr. Lv continues to make significant contributions to medical science and the development of her specialty in Shandong Province and beyond.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

    • Circ_0058124 upregulates MAPK1 expression to promote proliferation, metastasis and metabolic abilities in thyroid cancer through sponging miR-940
      • Authors: Sun, D., Chen, L., Lv, H., Liu, X., Zhang, X.
      • Journal: OncoTargets and Therapy
      • Year: 2020

     

    • Predicting biomarkers in laryngeal squamous cell carcinoma based on the cytokine-cytokine receptor interaction pathway
      • Authors: Chen, Q., Wang, D., Chen, Z., Li, P., Lv, H.
      • Journal: Heliyon
      • Year: 2024

     

    • Genetically predicted allergic rhinitis causally increases the risk of erectile dysfunction
      • Authors: Li, P., Meng, Z., Lin, L., Chen, Z., Lv, H.
      • Journal: Frontiers in Genetics
      • Year: 2024

     

    • A novel frameshift mutation of the endoglin (ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family
      • Authors: Li, P., Gao, C., Wei, Y., Shao, Q., Lv, H.
      • Journal: European Archives of Oto-Rhino-Laryngology
      • Year: 2024

     

    • Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-ฮฒ signaling pathway
      • Authors: Chen, L., Sun, D.-Z., Fu, Y.-G., Gao, Y., Zhang, X.-Y.
      • Journal: Cellular Signalling
      • Year: 2020

Prof. Hongsheng Liu | Pharmaco-Oncology | Best Researcher Award

Published on by Oncology

Prof. Hongsheng Liu | Pharmaco-Oncology | Best Researcher Award

Liaoning University | China

Author Profile

Scopus

๐ŸŒŸ Professor Hongsheng Liu: A Pioneer in Microbiology and Bioinformatics

Professor, School of Pharmaceutical Sciences, Liaoning University, China

๐Ÿ”ฌ Academic and Professional Background

Professor Hongsheng Liu obtained a Master’s degree in Microbiology from China Agricultural University in 1991 and later pursued a Ph.D. in Microbiology and Bioinformatics at Gifu University School of Medicine, Japan, in 2004. Over the years, he has expanded his expertise by serving as a visiting scholar at prestigious institutions such as Wuhan University, the University of Hong Kong, Harvard Medical School, and Hebrew University of Jerusalem. His career reflects a deep commitment to advancing the fields of microbiology, bioinformatics, and pharmaceutical sciences.

๐Ÿ’ก Research and Innovations

Professor Liu has completed an impressive 74 research projects and authored over 100 journal articles (SCI, Scopus, etc.), accumulating a citation index of 2721. His work spans diverse areas, including the discovery of the novel microorganism Paenibacillus liaoningensis sp. nov. and the investigation of influenza virus interactions. His contributions to computational biology include the development of several predictive algorithms and online platforms like CarcinoPred-EL and LiverToxPred-EL. Additionally, Professor Liu holds 37 patents, has published 4 books, and has led 7 industry consultancy projects.

๐Ÿ“š Published Works and Collaborations

Professor Liuโ€™s collaborative research includes partnerships with renowned institutions such as the University of Toledo, Harvard Medical School, and Eberhard Karl University of Tรผbingen. He has also served as a guest editor for Frontiers in Microbiology (2017-2018). His dedication to both basic and applied research continues to push the boundaries of pharmaceutical sciences.

๐Ÿ‘ฅ Professional Memberships

He is an active member of the Chinese Society for Microbiology (CSM) and the Chinese Chemical Society (CCS).

๐ŸŒ Areas of Research

Professor Liu specializes in computer-aided drug design and the simulation of biomacromolecule interactions, with a focus on studying lncRNAs and disease relationships, and designing stable recombinant proteins using engineered bacteria.

๐Ÿ”” Conclusion

Professor Hongsheng Liu stands as a distinguished leader in microbiology and bioinformatics, contributing significantly to drug design, biomolecular simulation, and microbial discovery. His broad academic collaborations, cutting-edge innovations, and vast research output underscore his influence in the scientific community. Through his extensive work on predictive algorithms, microbial databases, and recombinant protein design, he has made impactful advancements in pharmaceutical sciences. With over 100 journal publications, 37 patents, and numerous prestigious collaborations, Professor Liuโ€™s dedication to advancing scientific knowledge and improving human health is truly commendable.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

    • Article Title: Ensemble multiclassification model for aquatic toxicity of organic compounds
      Authors: Li, X., Liu, G., Wang, Z., Liu, H., Ai, H.
      Journal: Aquatic Toxicology
      Year: 2023

     

    • Article Title: Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer
      Authors: Zhang, H., Feng, H., Yu, T., Ma, L., Liu, H.
      Journal: Scientific Reports
      Year: 2023

     

    • Article Title: CBIL-VHPLI: a model for predicting viral-host protein-lncRNA interactions based on machine learning and transfer learning
      Authors: Zhang, M., Zhang, L., Liu, T., Zhao, J., Liu, H.
      Journal: Scientific Reports
      Year: 2024

     

    • Article Title: Construction of highly active and stable recombinant nattokinase by engineered bacteria and computational design
      Authors: Wang, L., Meng, J., Yu, X., Zhang, L., Liu, H.
      Journal: Archives of Biochemistry and Biophysics
      Year: 2024

     

    • Article Title: Effects of dietary supplementation of gallic tannic acid on growth, intestinal digestive enzymes activity, innate immunity, morphology, and microbial composition of Cyprinus carpio
      Authors: Feng, H., Zhao, S., Ma, X., Liu, Z., Liu, H.
      Journal: Aquaculture International
      Year: 2024

Prof. Xiaodi Niu | Biosensor | Best Researcher Award

Published on by Oncology

Prof. Xiaodi Niu | Biosensor | Best Researcher Award

Jilin University | China

AUTHOR PROFILE

Scopus

๐Ÿง‘โ€๐ŸŽ“ NIU XIAODI โ€“ PROFESSOR, FACULTY OF VETERINARY MEDICINE, JILIN UNIVERSITY

๐ŸŽ“ EDUCATION BACKGROUND

  • 2005-09 to 2008-06: PhD in Natural Medicinal Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences
  • 2002-09 to 2005-07: Master’s in Physical Chemistry, Northeast Normal University
  • 1998-09 to 2002-07: Bachelorโ€™s in Chemistry Education, Northeast Normal University

๐Ÿง‘โ€๐Ÿ”ฌ POSTDOCTORAL WORK EXPERIENCE

  • 2014-06 to 2016-06: Postdoctoral Research, College of Veterinary Medicine, Jilin University

๐Ÿ‘ฉโ€๐Ÿซ SCIENTIFIC RESEARCH AND ACADEMIC WORK EXPERIENCE

  • 2018-01 to Present: Professor, College of Veterinary Medicine, Jilin University
  • 2010-09 to 2017-12: Associate Professor, College of Veterinary Medicine, Jilin University
  • 2008-07 to 2010-08: Lecturer, College of Veterinary Medicine, Jilin University

๐Ÿงช EARLY ACADEMIC PURSUITS

Niu Xiaodiโ€™s academic journey began with a Bachelorโ€™s in Chemistry Education, followed by a Master’s in Physical Chemistry from Northeast Normal University. She further honed her expertise by obtaining a PhD in Natural Medicinal Chemistry at the prestigious Changchun Institute of Applied Chemistry. These formative years laid a strong foundation for her subsequent academic and research endeavors, focusing on the interface of chemistry and veterinary medicine.

๐Ÿ… PROFESSIONAL ENDEAVORS

Throughout her career at Jilin University, Niu Xiaodi has progressed through various academic ranks, from Lecturer to Associate Professor, and currently serves as a full Professor in the College of Veterinary Medicine. Her postdoctoral work at the same institution further enriched her knowledge and research skills, particularly in veterinary pharmacology and molecular mechanisms of medicinal compounds.

๐Ÿ”ฌ RESEARCH FOCUS

Niuโ€™s research primarily revolves around natural medicinal chemistry and veterinary pharmacology, with a specific emphasis on the molecular mechanisms of bioactive compounds. Her notable research contributions include investigating the inhibition of bacterial enzymes and exploring anti-aging compounds targeting specific cellular proteins.

National Natural Science Foundation Projects

  1. Cyanidin Inhibits Staphylococcus aureus Serine/Threonine Protein Phosphatase (Stp1)
    • Project ID: 32072919
    • Duration: 2021-01-01 to 2024-12-31
    • Funding: RMB 580,000
    • Role: Principal Investigator
    • Focus: This project investigates the molecular mechanism of cyanidinโ€™s inhibition of Stp1 in Staphylococcus aureus and analyzes its structure-activity relationship, which may lead to the development of new antibacterial agents.

 

  1. Theaflavins Inhibition of Class B ฮฒ-Lactamase
    • Project ID: 31872525
    • Duration: 2019-01-01 to 2022-12-31
    • Funding: RMB 600,000
    • Role: Host
    • Focus: This research focuses on the structural analysis of theaflavins, a type of polyphenol, in their ability to inhibit Class B ฮฒ-lactamase enzymes, which are responsible for antibiotic resistance.

Other Research Projects

  1. Anti-Aging Activity of Ursolic Acid Targeting AMP-Activated Protein Kinase (AMPK)
    • Funding Source: Jilin Provincial Department of Science and Technology
    • Project ID: 20190701032GH
    • Duration: 2019-01 to 2021-12
    • Funding: RMB 150,000
    • Role: Principal Investigator
    • Focus: This project examined how ursolic acid, a natural compound, activates AMPK to combat aging, highlighting potential therapeutic applications for age-related diseases.

๐ŸŒ IMPACT AND INFLUENCE

Niu Xiaodiโ€™s work has made significant contributions to both the fields of veterinary medicine and natural product chemistry. Her research on inhibiting bacterial enzymes addresses the growing issue of antibiotic resistance, a global health crisis. Additionally, her exploration of natural compounds with anti-aging properties has implications for longevity research and the development of therapeutic interventions for age-related diseases.

๐Ÿ“š ACADEMIC CITATIONS AND LEGACY

Niu Xiaodiโ€™s publications are widely cited in the fields of medicinal chemistry and veterinary pharmacology, reflecting the relevance and impact of her work. Her insights into the structure-activity relationships of bioactive compounds are particularly influential in guiding future drug development. With a robust track record of research projects, including National Natural Science Foundation projects, her contributions continue to shape academic discourse and practical applications in the medical and veterinary fields.

๐Ÿš€ FUTURE CONTRIBUTIONS

Looking ahead, Niu Xiaodi aims to expand her research into novel therapeutic strategies targeting antibiotic resistance and cellular aging. Her future work will likely delve deeper into the mechanisms of bioactive compounds, unlocking new potential in both veterinary medicine and human health.

Through her extensive academic journey, pioneering research, and impactful contributions, Niu Xiaodi has established herself as a key figure in medicinal chemistry and veterinary science. Her ongoing work promises to leave a lasting legacy in these interdisciplinary fields.

๐Ÿš€ CONCLUSION

Niu Xiaodi’s impressive academic and professional journey reflects her dedication to advancing the fields of veterinary medicine and medicinal chemistry. With a solid educational foundation and extensive research experience, she has made significant contributions to understanding the biochemical mechanisms of natural compounds in combating bacterial resistance and promoting health. Her leadership in key projects has not only yielded valuable insights but also addressed pressing challenges in antibiotic resistance and aging.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

    • Engineering the electronic structure of isolated manganese sites to improve the oxygen reduction, Zn-air battery and fuel cell performances
      • Authors: Bai, X., Wang, Y., Han, J., Niu, X., Guan, J.
      • Journal: Applied Catalysis B: Environmental
      • Year: 2023

     

    • Diatomic Fe-Co catalysts synergistically catalyze oxygen evolution reaction
      • Authors: Tang, T., Han, J., Wang, Z., Niu, X., Guan, J.
      • Journal: Nano Research
      • Year: 2024
    • Novel metallo-ฮฒ-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria
      • Authors: Guo, Y., Liu, H., Yang, M., Feng, H., Qiu, J., Niu, X.
      • Journal: British Journal of Pharmacology
      • Year: 2024

     

    • Dibenzylideneacetone Overcomes Botrytis cinerea Infection in Cherry Tomatoes by Inhibiting Chitinase Activity
      • Authors: Niu, X., Wang, Z., Wang, C., Wang, H.
      • Journal: Journal of Agricultural and Food Chemistry
      • Year: 2023

     

    • Exploring Novel Umami Peptides from Bovine Bone Soups Using Nano-HPLC-MS/MS and Molecular Docking
      • Authors: Yang, Z., Li, W., Yang, R., Li, G., Zhao, C.
      • Journal: Foods
      • Year: 2024

Mr. Zhongyun Yuan | Magnetoelastic sensor | Best Researcher Award

Published on by Oncology

Mr. Zhongyun Yuan | Magnetoelastic sensor | Best Researcher Award

Taiyuan University of Technology | China

AUTHOR PROFILE

Scopus

๐ŸŽ“ EARLY ACADEMIC PURSUITS

Zhongyun Yuan embarked on his academic journey in Electronic and Computer Engineering at Sungkyunkwan University, Korea, where he earned his Doctor of Engineering (D.Eng) degree between February 2010 and February 2014. During this period, Yuan honed his expertise in micro and nano systems, computer engineering, and other advanced technological fields. His doctoral research laid the foundation for his future contributions to the academic and research communities.

๐Ÿ’ผ PROFESSIONAL ENDEAVORS

Yuan’s professional trajectory began with postdoctoral research at the VADA Lab, as part of the prestigious BK21 Talent Program at Sungkyunkwan University, Korea, from March 2014 to July 2016. This role allowed him to deepen his research in advanced computing systems and microelectronics. Following this, he transitioned into academia, serving as an Adjunct Professor at Sungkyunkwan University and a Part-time Lecturer at Soongsil University, where he shared his knowledge of computer science and communication systems with students.

In December 2016, Zhongyun Yuan became an Associate Professor at the Micro Nano Systems Research Center at Taiyuan University of Technology, marking a significant leap in his career. His time at Hanyang University, Korea, as a Visiting Professor from June 2020 to June 2022, further enhanced his international exposure and collaborations.

๐Ÿ”ฌ CONTRIBUTIONS AND RESEARCH FOCUS ON MAGNETOELASTIC SENSOR

Professor Yuan’s research has focused on micro and nano systems, particularly in the intersection of electronics, computing, and nanotechnology. His work includes exploring advanced communication systems, microelectronics, and the application of nano-scale engineering in various fields. His interdisciplinary approach has enabled the development of cutting-edge technologies and the creation of more efficient computing architectures.

๐ŸŒ IMPACT AND INFLUENCE

Yuan’s research has had a profound impact, particularly in Asia and internationally, where his collaborations in Korea and China have influenced the direction of nano-system applications in engineering. As a result of his extensive research and teaching, he has mentored numerous graduate students and postdocs, contributing to the next generation of innovators in the fields of computer science, nanoengineering, and microelectronics.

๐Ÿ“š ACADEMIC CITES

Yuan’s academic publications have been widely cited in international journals, reflecting the significance of his contributions to micro-nano systems and computer engineering. His work has garnered attention in fields such as electronic engineering and applied nanotechnology, placing him as a key thought leader in these domains. His collaboration with leading institutions in Korea and China further amplifies his influence.

๐Ÿ† LEGACY AND FUTURE CONTRIBUTIONS

As an established researcher and educator, Professor Zhongyun Yuan is poised to leave a lasting legacy in the fields of micro and nano systems. His work has already advanced the technological capabilities of nano-engineered computing systems, and his future contributions are likely to push the boundaries of what is possible in information systems and communication technologies. He continues to inspire his students and colleagues, ensuring that his research and teachings will impact academia and industry for years to come.

Through his academic journey and professional endeavors, Zhongyun Yuan has established himself as a pivotal figure in advancing micro and nano systems and pioneering innovative approaches in electronic and computer engineering. His dedication to research and teaching will undoubtedly influence future technological advancements in the global arena.

๐Ÿš€ CONCLUSION

Zhongyun Yuan’s journey from a doctoral student at Sungkyunkwan University to an Associate Professor at Taiyuan University of Technology showcases his remarkable dedication to the fields of micro and nano systems. His professional experience across top institutions in Korea and China has positioned him as a leader in electronic and computer engineering. Through his research, teaching, and mentorship, Yuan has significantly advanced the application of nano-scale technologies and microelectronics, impacting both academia and industry.

His influence is evident in the numerous citations of his work, and his contributions continue to shape the future of information systems and communication technologies. As he advances his research and engages in new collaborations, Professor Yuan’s legacy will endure, making lasting contributions to the technological and academic landscapes.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

    • Title: A cost-effective smartphone-based device for rapid C-reaction protein (CRP) detection using magnetoelastic immunosensor
      Authors: Yuan, Z., Han, M., Li, D., Xing, Z., Zhao, C.
      Journal: Lab on a Chip
      Year: 2023

     

    • Title: End-to-End Automatic Classification of Retinal Vessel Based on Generative Adversarial Networks with Improved U-Net
      Authors: Zhang, J., Yang, K., Shen, Z., Zhang, Q., Cai, M.
      Journal: Diagnostics
      Year: 2023

     

    • Title: Magneto-stress-electric-coupled biosensors originated in magnetostrictive effect for sensitization
      Authors: Sang, S., Ge, Y., Ji, J., Zhao, D., Dong, X.
      Journal: Sensors and Actuators B: Chemical
      Year: 2023

     

    • Title: Electric Field-Induced Magnetic Anisotropies in Fe3GeTe2-Based Nanoheterostructures
      Authors: Jiang, J., Wu, K., Wang, J., Sang, S., Ge, Y.
      Journal: ACS Applied Nano Materials
      Year: 2024

     

    • Title: A smartphone-based multichannel magnetoelastic immunosensor for acute aortic dissection supplementary diagnosis
      Authors: Cao, Y., Wang, Q., Han, M., Jin, H., Zhao, C.
      Journal: Talanta
      Year: 2025

Dr. Kwadwo Ansong Asante | Ecotoxicology | Best Researcher Award

Published on by Oncology

Dr. Kwadwo Ansong Asante | Ecotoxicology | Best Researcher Award

CSIR Water Research Institute | Ghana

AUTHOR PROFILE

ORCID ID

๐ŸŽ“EARLY ACADEMIC PURSUITSย 

Dr. Kwadwo Ansong Asante began his academic journey with a B.Sc. (Hons) in Chemistry from the University of Science and Technology, Ghana in August 1993. His passion for environmental research led him to pursue further studies at Ehime University, Japan, where he earned an M.Sc. in Environmental Chemistry and Ecotoxicology in September 2005. His educational background includes certificates from prestigious institutions such as the Danish Hydraulic Institute (Denmark), University of Hamburg (Germany), University of Helsinki (Finland), Lancaster University (UK), and Ehime University (Japan), culminating in a D.Sc. in Environmental Chemistry in March 2012.

๐ŸŒPROFESSIONAL ENDEAVORSย 

Dr. Asante has established himself as a Principal Research Scientist and has held various leadership roles, including Head of Division at the CSIR Water Research Institute, Ghana, where he has been a key player since 2017. His expertise in environmental chemistry and water management is demonstrated by his numerous roles as Acting Director of the Institute in 2024 and 2018. He has also led the Environmental Chemistry and Sanitation Engineering Division, spearheading innovative research and administrative responsibilities since 2022. His leadership extends to national and international arenas, serving as a CSIR Representative on Ghana’s Hazardous Chemicals Committee and a member of the UNIDO Technical Working Group on Ghanaโ€™s Health and Pollution Action Plan.

๐Ÿ”ฌCONTRIBUTIONS AND RESEARCH FOCUSย 

Dr. Asante’s research is focused on environmental chemistry, water management, and ecotoxicology, with a strong emphasis on pollution control and water treatment technologies. He has played significant roles in evaluating environmental technologies, particularly for mine wastewater treatment, collaborating with experts from Israel and South Africa. His extensive research experience extends beyond Ghana, with collaborative projects in Ivory Coast and Burkina Faso, further enhancing his impact in West Africa.

He has also contributed to the academic community as a reviewer for high-impact Elsevier journals such as Environment International, Chemosphere, and STOTEN, and serves as an external examiner for universities in Ghana, South Africa, and India.

๐ŸŒฑIMPACT AND INFLUENCEย 

Dr. Asante’s work has influenced policy and practice in environmental protection and water management, both locally and internationally. As a member of the International Panel on Chemical Pollution (IPCP) and an advisory board member for the Sustainable Chemistry for the Environment Journal, he has contributed to shaping global discussions on sustainable environmental practices. His role in WHOโ€™s “E-waste exposure and childrenโ€™s health” network highlights his commitment to tackling global environmental health challenges.

๐Ÿ“šACADEMIC CITES AND LEGACYย 

Dr. Asanteโ€™s academic legacy is marked by his supervision of students and scholars, including a Fulbright Scholar from Michigan State University. His research outputs have been widely cited, and his ongoing collaborations and advisory roles ensure that his work continues to have a lasting impact on future generations of scientists. His contributions to student supervision, research program design, and project implementation showcase his dedication to nurturing emerging talent in environmental science.

๐Ÿ”ฎFUTURE CONTRIBUTIONS ๐Ÿ”ฎ

Dr. Asanteโ€™s future endeavors are likely to focus on expanding his research on water management and environmental protection technologies. His continuous involvement in international collaborations, policy advisory roles, and research supervision will ensure that his contributions to science and sustainable environmental management remain influential both in Ghana and globally.

๐ŸŒŸCONCLUSIONย 

Dr. Kwadwo Ansong Asante stands as a distinguished leader in environmental chemistry and water research, with a career that has spanned academia, research, and international collaborations. His commitment to advancing water management solutions, pollution control, and environmental protection has made a significant impact both in Ghana and beyond. Through his roles as a Principal Research Scientist, Head of Division, and international advisor, he has not only contributed to scientific knowledge but also helped shape policies and technologies for a more sustainable future. His legacy of mentorship, extensive research contributions, and influence on global environmental health issues ensures that his work will continue to resonate for years to come. ๐ŸŒโœจ

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

    • Complex Mixtures of Brominated/Chlorinated Diphenyl Ethers and Dibenzofurans in Soils from the Agbogbloshie e-Waste Site (Ghana): Occurrence, Formation, and Exposure Implications.
      • Authors: Shunthirasingham, C., S. N. Kukuฤka, K. G. Abdallah, K. A. Asante, D. Fusu, M. Liu, K. C. Jones, H. Fiedler
      • Journal: Environmental Science & Technology
      • Year: 2019

     

    • Prevention-Intervention Strategies to Reduce Exposure to E-Waste.
      • Authors: Caravanos, J., A. A. Clarke, K. A. Asante, S. Amoyaw-Osei, R. E. Thompson
      • Journal: Reviews on Environmental Health
      • Year: 2018

     

    • Oxidative Stress and Respiratory Symptoms Due to Human Exposure to Polycyclic Aromatic Hydrocarbons (PAHs) in Kumasi, Ghana.
      • Authors: Arku, R. E., B. A. Brauer, M. E. Osei-Kofi, K. A. Asante, F. Nyarko, C. Hystad
      • Journal: Environmental Pollution (Barking, Essex: 1987)
      • Year: 2017

     

    • Occurrence, Profiles, and Toxic Equivalents of Chlorinated and Brominated Polycyclic Aromatic Hydrocarbons in E-Waste Open Burning Soils.
      • Authors: Liu, G., X. Wei, K. A. Asante, M. I. Diamond, K. C. Jones
      • Journal: Environmental Pollution (Barking, Essex: 1987)
      • Year: 2017

     

    • E-Waste Interventions in Ghana.
      • Authors: Asante, K. A., J. Caravanos, R. E. Thompson
      • Journal: Reviews on Environmental Health
      • Year: 2016

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

Published on by Oncology

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

University of Nouakchott | Mauritania

Author Profile

Scopus

ORCID ID

Dr. Mohamed Lemine Cheikh Brahim Ahmed

๐ŸŽ“Education :

  • PhD in Public Health ๐Ÿงฌ
    Universitรฉ Mohammed V, Rabat, Morocco
  • Master of Public Health in Molecular Epidemiology of Zoonotic Diseases ๐Ÿฆ ๐Ÿ”ฌ
    IAV Hassan II, Rabat, Morocco
  • Certificate in Molecular Biology and Bioinformatics ๐Ÿงฌ๐Ÿ’ป
    Hua Zhong Normal University, Wuhan, China

๐ŸŒProfessional Memberships :

  • Member of the World Society for Virology (WSV) ๐Ÿงซ
  • Member of the International Covid-19 Research Network (ICRN) ๐Ÿฆ 
  • Member of the One Health Heukelbach Institute ๐ŸŒฑ
  • Member of the MENA Coalition for HPV Elimination ๐Ÿ’‰
  • Member of the Research Unit on Molecular Epidemiology and Microorganism Diversity (EMDM) ๐Ÿงฌ
  • President of the Mauritanian Society for Scientific Research (AMDRS) ๐Ÿง‘โ€๐Ÿ”ฌ
  • Collaborator on the Global Burden of Diseases (GBD) project, Institute for Health Metrics and Evaluation, University of Washington ๐ŸŒŽ

๐Ÿ’กKey Skills :

  • Vaccine Coordination & Logistics ๐Ÿšš๐Ÿ’‰:

  • Planned and supervised vaccine logistics for remote regions in Mauritania, ensuring stock management and quality control practices for vaccines like PCV13 and Rotarix.

  • Public Health Communication & Training ๐Ÿ“ข๐Ÿ‘ฉโ€โš•๏ธ:

  • Conducted team-building and training sessions for local health personnel, focusing on routine and Covid-19 vaccination campaigns.

  • Research Project Management ๐Ÿง‘โ€๐Ÿ”ฌ๐Ÿ“Š:

  • Led public health research projects, managing performance indicators, and reporting on vaccine distribution and health systems.

  • Flexibility & Versatility โš™๏ธ:

  • Adapted to various challenges in vaccine distribution and epidemiological surveillance, especially during pandemics.

โœ…Main Qualifications :

Vaccination ๐Ÿ’‰:

  • Supervised and trained local teams for stock management and quality control of vaccines across remote areas in Mauritania.
  • Led national Covid-19 vaccination strategy development, training teams and evaluating the impact of vaccine introductions (e.g., PCV13, Rotarix).
  • Coordinated routine vaccination campaigns across all 15 regions of Mauritania and introduced critical vaccines like nVPO2 for polio.

Epidemiological Surveillance ๐Ÿงฌ:

  • Developed and implemented national strategies for combatting Covid-19, including plans for testing diseases like measles, polio, hemorrhagic fevers, and HPV.
  • Organized and led sentinel surveillance programs for diseases like rotavirus and influenza.
  • Conducted performance evaluations of Mauritania’s health information systems and trained response teams for integrated epidemiological surveillance.

๐ŸขRecent Professional Experience :

National Consultant

UNICEF, Mauritania (Feb 2022 – Jul 2022)
Supported cold chain logistics and vaccine management for poliomyelitis response campaigns. Key tasks included overseeing vaccine distribution, supporting data analysis, and participating in meetings for budget planning with GPEI.

  • Provided technical assistance for vaccine logistics, ensuring the collection and destruction of unusable vaccine vials.
  • Led training sessions for independent monitors and LQAS surveyors to evaluate the polio vaccination campaign.

๐Ÿ“ˆ Conclusion๐ŸŒŸ

Dr. Mohamed Lemine Cheikh Brahim Ahmed is a highly skilled expert in vaccination logistics and epidemiological surveillance ๐Ÿฆ ๐Ÿ’‰, with extensive experience in public health, research management, and disease control. His work spans from developing national vaccination strategies, including Covid-19, to training teams and overseeing campaigns in remote regions of Mauritania. As a member of numerous global health organizations ๐ŸŒ and a key contributor to projects like the Global Burden of Diseases ๐ŸŒŽ, he is committed to improving public health outcomes through innovative approaches and evidence-based strategies. Dr. Ahmedโ€™s versatility, leadership, and dedication make him a valuable asset in the field of global health and vaccination efforts.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

    • Article: Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis
      • Authors: Abou Ghayda, R., Lee, K.H., Han, Y.J., Smith, L., Shin, J.I.
      • Journal: Journal of Medical Virology
      • Year: 2022

     

    • Article: Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
      • Authors: Park, S.H., Hong, S.H., Kim, K., Il Shin, J., Smith, L.
      • Journal: Journal of Medical Virology
      • Year: 2023

     

    • Article: COVID-19 outbreak in Mauritania: Epidemiology and health system response
      • Authors: Ahmed, M.L.C.B., Zehaf, S., El Alem, M.M., Abdellahi, M.V.M., Heukelbach, J.
      • Journal: Journal of Infection in Developing Countries
      • Year: 2021

Dr. Luguterah Austin Wontepaga | Sports | Best Researcher Award

Published on by Oncology

Dr. Luguterah Austin Wontepaga | Sports | Best Researcher Award

University Of Ghana | Ghana 

AUTHOR PROFILE

Google Scholar

ORCID ID

DR. LUGUTERAH AUSTIN WONTEPAGA: UNIVERSITY OF GHANA SPORTS EXPERT

๐Ÿ“šEARLY ACADEMIC PURSUITSย 

Dr. Luguterah Austin Wontepaga began his academic journey with a strong foundation in sports policy and public administration. He earned his PhD in Public Administration, with a focus on Sports Policy, from the University of South Africa. His early education fostered his interest in how sports intersect with administration and governance, paving the way for his impactful career.

๐Ÿ†PROFESSIONAL ENDEAVORSย 

Dr. Wontepaga is a Senior Lecturer and Head of the Department of Physical Education and Sport Studies at the University of Ghana. In addition to his academic role, he actively participates in the sports world as the Vice President of the Ghana Volleyball Association and Chairman of the Development Commission for the Confederation of African Volleyball-Zone 3. His professional work goes beyond teaching, with significant involvement in the development and management of sports at national and continental levels.

๐ŸงCONTRIBUTIONS AND RESEARCH FOCUSย 

Dr. Wontepagaโ€™s research interests are rooted in sports for development, sports policy, sports coaching, and sports management. He has contributed substantially to understanding how sports can drive development, especially in Africa. His research includes extensive peer-reviewed journal articles, and he has undertaken significant projects that impact the formulation of sports policies in Ghana and beyond.

๐ŸŒIMPACT AND INFLUENCEย 

As a key figure in Ghana’s sports landscape, Dr. Wontepaga has played a pivotal role in shaping sports education and policy. His work emphasizes using sports as a tool for social and economic development, particularly focusing on the role of sports in youth empowerment and community cohesion. His leadership within African volleyball extends his influence across the continent, contributing to the growth of the sport at both grassroots and elite levels.

๐Ÿ“œACADEMIC CITATIONS AND RECOGNITIONย 

Dr. Wontepaga has authored numerous peer-reviewed journal articles, many of which have been widely cited within the academic community. His research has influenced policies and practices related to sports development, earning him recognition both locally and internationally. His academic contributions are regularly referenced by scholars and policymakers in the field of sports management.

๐Ÿ…LEGACY AND FUTURE CONTRIBUTIONSย 

Dr. Luguterah Austin Wontepagaโ€™s legacy in the sports and academic communities is already well established. His work in sports policy and development is creating lasting change in how sports are used to foster development and education. Moving forward, his continued leadership at the University of Ghana and in various sporting organizations is expected to drive innovation and growth, especially in sports management and coaching education. His future contributions will likely focus on expanding the role of sports as a developmental tool across Africa, ensuring that sports remain a key element in youth development and policy formulation.

๐Ÿ’กFINAL THOUGHTSย 

Dr. Wontepaga is a dynamic figure in sports academia and leadership. His work not only strengthens Ghanaโ€™s sports education framework but also influences broader sports policy on the African continent. His dedication to sports development, research, and policymaking ensures his impact will be felt for generations to come.

๐Ÿ“ˆ CONCLUSION ๐ŸŒŸ

Dr. Luguterah Austin Wontepaga stands as a key figure in sports academia, policy, and development both in Ghana and across Africa. His profound contributions through teaching, research, and leadership have reshaped the landscape of sports education and management. His work in using sports as a vehicle for social and economic development showcases his commitment to empowering communities and advancing youth potential. As he continues to influence sports policy and development, his legacy is firmly established, and his future contributions are set to further elevate sports as a critical tool for African development. Dr. Wontepagaโ€™s impact on academia, sports governance, and youth empowerment will undoubtedly leave a lasting mark on both the academic world and the sporting community.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

    • Exploration of science teaching self-efficacy outside professional development context for inquiry-based teaching
      • Authors: Salifu Maigari Mohammed, Austin Wontepaga Luguterah
      • Journal: Cogent Education
      • Year: 2024

     

    • The capabilities of sports as an option for poverty reduction strategy: Citizen perspective
      • Authors: Austin Wontepaga Luguterah, Salifu Maigari Mohammed, Daniel Apaak, Richard Samuel Kwadwo Abieraba
      • Journal: Journal of Community & Applied Social Psychology
        Year: 2024

     

    • Exploration of Science Teaching Self-Efficacy Sources from Multiple Narratives of Professional Development Experiences
      • Authors: Salifu Maigari Mohammed, Austin Wontepaga Luguterah
      • Journal: African Journal of Empirical Research
      • Year: 2024

     

    • Interaction Between Coaches and Athletes in African Nations During the Lockdown Period of COVID-19
      • Authors: Austin W Luguterah, Usman Abonyi, Rita Yeboah, Alliance Kubayi
      • Journal: International Sport Coaching Journal
      • Year: 2023

     

    • Motivations of pre-service teachers in the colleges of education in Ghana for choosing teaching as a career
      • Authors: Usman Kojo Abonyi, Doreen Awhireng, Austin Wontepaga Luguterah
      • Journal: Cogent Education
      • Year: 2021

Dr. Pengchong Wang | Cancer Therapy | Best Researcher Award

Published on by Oncology

Dr. Pengchong Wang | Cancer Therapy | Best Researcher Award

Shaanxi Provincial People’s Hospital | China

AUTHOR PROFILE

Scopus

๐Ÿ’Š WANG PENGCHONG: ACADEMIC PROFILE AND ACHIEVEMENTS ๐ŸŽ“

๐ŸŽ“EARLY ACADEMIC PURSUITS ๐Ÿ“š

Wang Pengchong, the Chief Pharmacist at Shaanxi Provincial People’s Hospital, earned his PhD in Pharmacy from Xi’an Jiaotong University. His academic journey was shaped by a focus on tumor pharmacy and targeted drug delivery systems. His early years were spent delving into the intricacies of pharmaceutical care, particularly in the context of oncology, laying the foundation for his future breakthroughs.

๐Ÿ’ผ PROFESSIONAL ENDEAVORS ๐Ÿฅ

Wang is a dedicated member of the Pharmaceutical Care Committee of the Shaanxi Pharmacological Society. His professional work has revolved around tumor pharmacology, pioneering approaches to targeted cancer treatments. He has played an instrumental role in several major projects, including three general projects funded by the National Natural Science Foundation of China and two key R&D projects in Shaanxi Province. His leadership in high-profile initiatives highlights his influence on pharmaceutical advancements.

๐Ÿ”ฌ CONTRIBUTIONS AND RESEARCH FOCUS ๐ŸŽฏ

Wang Pengchong’s research is centered on targeted drug delivery systems and tumor pharmacy research. His contributions are geared toward improving cancer therapies by focusing on precision medicine, which minimizes side effects and enhances the effectiveness of treatment. His work extends into innovative methods, such as nanotechnology in drug targeting. Wang has led multiple significant projects, including the Shaanxi Province Science and Technology Plan Project, the Xi’an City Science and Technology Plan Project, and the Yaodong Shenzhou Pharmaceutical Research Capacity Building Project.

โœจ IMPACT AND INFLUENCE ๐ŸŒ

Wang’s research has had a profound impact on cancer treatment strategies and pharmaceutical care. His efforts have advanced both the scientific understanding and practical application of cancer drugs, particularly in how they can be precisely targeted to tumor cells while sparing healthy tissues. Through his leadership in government-backed research initiatives, Wang has become a driving force in the field, influencing not just Shaanxi Province but the broader pharmaceutical landscape.

๐Ÿ“Š ACADEMIC CITES ๐Ÿ“„

In the past five years, Wang Pengchong has published more than ten SCI-indexed papers in international journals. His work is widely cited, particularly in oncology and pharmaceutical sciences. His research topics span from cutting-edge drug delivery systems to therapeutic advancements, solidifying his reputation in the global scientific community.

๐ŸŒ LEGACY AND FUTURE CONTRIBUTIONS ๐Ÿ†

Wang Pengchongโ€™s legacy will continue to grow as he contributes to targeted cancer therapies and pharmaceutical innovations. His role in advancing precision medicine ensures that his work will influence the next generation of cancer treatments. By leading critical projects and setting new benchmarks in oncology pharmacy, Wang is shaping the future of drug delivery systems and cancer care. His ongoing commitment to pharmaceutical research guarantees that his contributions will leave a lasting impact on the field.

๐Ÿ“ˆ CONCLUSION ๐ŸŒŸ

Wang Pengchongโ€™s distinguished career as a Chief Pharmacist and researcher has made significant strides in the fields of targeted drug delivery systems and tumor pharmacy. His academic foundation, coupled with leadership in high-impact research projects, has not only advanced cancer treatment but also positioned him as a key contributor to pharmaceutical sciences. With over a decade of impactful publications and successful project leadership, Wangโ€™s research continues to shape the future of oncology treatments, fostering innovations that will benefit patients worldwide. His work embodies a lasting legacy of precision medicine and cutting-edge cancer therapies, ensuring he remains a pivotal figure in pharmaceutical research and development. ๐ŸŒ๐Ÿ”ฌ

 

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

    • Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis
      • Authors: Yan, Y., Sun, Y., Wang, P., Xing, J., Dong, Y.
      • Journal: Carbohydrate Polymers
      • Year: 2020

     

    • An improved synthesis of water-soluble dual fluorescence emission carbon dots from holly leaves for accurate detection of mercury ions in living cells
      • Authors: Wang, P., Yan, Y., Zhang, Y., Xing, J., Dong, Y.
      • Journal: International Journal of Nanomedicine
      • Year: 2021

     

    • One-pot synthesis of nuclear targeting carbon dots with high photoluminescence
      • Authors: Wang, P., Ji, H., Guo, S., Xing, J., Dong, Y.
      • Journal: Chinese Chemical Letters
      • Year: 2021

     

    • Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis
      • Authors: Wang, P., Zhang, Y., Lei, H., Xing, J., Dong, Y.
      • Journal: Carbohydrate Polymers
      • Year: 2023

     

    • Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy
      • Authors: Dong, K., Chen, W., Zhao, Z., Lu, T., Dong, Y.
      • Journal: Biomaterials Advances
      • Year: 2022

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

Published on by Oncology

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

IQVIA | Netherlandsย 

Author Profile

Scopus

๐ŸŒMrs. Anke van Engen ๐Ÿ’ผ

  • Managing Principal, IQVIA Payer Evidence Solutions
    Amsterdam, the Netherlands

๐Ÿ”ฌProfile:

  • Anke van Engen is a seasoned expert with over 20 years of experience in health economics, outcomes research, and market access strategy. Her work focuses on helping life sciences companies achieve greater commercial success through integrated payer evidence strategies. Anke is well-regarded for building lasting partnerships, consistently delivering results, and serving as a trusted advisor to clients. She excels at leading international teams across EMEA, using her coaching and training abilities to inspire success.

๐Ÿ‘จโ€โš•๏ธKey Specialties:

  • ๐Ÿ“šGeneral management
  • ๐ŸŒStrategic planning & business development
  • ๐ŸฉบHealth economics & outcomes research (HEOR)
  • ๐ŸฅMarket access strategy (MA) & execution
  • ๐Ÿ’‰Health technology assessment (HTA)
  • ๐Ÿ“Client relationship management & coaching

๐Ÿ’ผProfessional Experience:

  • ๐ŸŒŸ2023 โ€“ Present: Managing Principal, IQVIA Value & Payer Evidence
    • Co-leads EMEA Real World Evidence Leadership Team
    • Oversees integrated evidence & EU HTA offerings
  • ๐Ÿ’ก2020 โ€“ 2023: Senior Principal, IQVIA Real World Solutions
    • Led the development of EMEA payer evidence solutions
    • Drove go-to-market strategy and key client partnerships
  • ๐ŸŒ2017 โ€“ 2020: Senior Principal, IQVIA Consulting Services
    • Managed partnerships with large pharmaceutical clients
    • Led the HTA Accelerator solution for launch readiness
  • ๐Ÿš€2014 โ€“ 2017: Principal, Quintiles Advisory Services
    • Led development of the flagship HTA Accelerator platform
    • Senior oversight on HEOR/MA strategy and projects

๐ŸŽ“Education:

  • ๐ŸงชMSc in Chemistry (Bio-organic Chemistry), University of Leiden, The Netherlands
  • ๐Ÿ“ŠBusiness leadership programs at IMD, Lausanne, Switzerland

๐ŸŒProfessional Affiliations:

  • ๐ŸงฌActive member of ISPOR and HTAi
  • ๐Ÿ’กIQVIA representative at GetReal Institute

๐Ÿ…Awards & Honors:

  • ๐ŸŒŸ2023: Issue panel ranked #1 at ISPOR Europe
  • ๐Ÿฆˆ2014: Won Sharktank contest for HTA Accelerator innovation
  • ๐Ÿ†Multiple ISPOR awards for best podium and poster presentations

 

๐Ÿ” Conclusion
  • ๐Ÿ’ผIn conclusion, Anke van Engen is a highly respected leader in the field of health economics, outcomes research, and market access strategy, with a proven track record of guiding life sciences companies toward commercial success. Her expertise in building long-term client partnerships, managing international teams, and delivering innovative payer evidence solutions has solidified her reputation as a trusted advisor. With over two decades of experience and numerous accolades, Anke continues to shape the future of healthcare consultancy by integrating strategic insights and real-world evidence. ๐ŸŒ

 

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

    • The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment
      • Authors: van Engen A, Krรผger R, Parnaby A, Rotaru M, Ryan J, Samaha D, Tzelis D
      • Journal: Value Health
      • Year: 2024

     

    • Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials
      • Authors: Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J
      • Journal: Value Health
      • Year: 2021

     

    • Call in the PROs: Giving Credence to the Patientโ€™s Perspective in Healthcare Decision Making
      • Authors: van Engen A, New M, Beatrice Bรถhler Y, Holmstrom S, Boerlum Kristensen F
      • Journal: ISPOR Value & Outcomes Spotlight
      • Year: 2020

Dr Ghanshyam Ghelani | Bladder Cancer | Best Researcher Award

Published on by Oncology

Dr Ghanshyam Ghelani | Bladder Cancer | Best Researcher Award

SUNY Upstate Medical University | United States 

Author Profile

Scopus

ORCID Id

๐ŸฉบGhanshyam Ghelani, MD ๐Ÿ’‰

Hematology-Oncology Fellow & Clinical Investigator
SUNY Upstate Medical University, Syracuse, NY

๐ŸŽ“ Education

  • M.B.B.S. โ€“ B.J. Medical College, Ahmedabad, Gujarat, India (09/2002 โ€“ 03/2008)
    ๐Ÿ“š Ranked in the top 10% of a class of 250 students.
  • Internal Medicine Residency โ€“ The Wright Center for Graduate Medical Education, Scranton, PA, USA (07/2013 โ€“ 06/2016)
    ๐Ÿฅ Completed residency at affiliate hospitals including Geisinger CMC and VA Medical Center.
    ๐Ÿ… Awarded M.D. by New York State on November 16, 2016.
  • Hematology-Oncology Fellowship โ€“ SUNY Upstate Medical University, Syracuse, NY (07/2021 โ€“ 06/2024)
    ๐Ÿ’‰ Active Member of the Transfusion Medicine Committee and Hematology-Oncology Representative of the Resident and Fellow Forum.

๐Ÿ’ผ Certifications and Licensure

  • Board Certification โ€“ The American Board of Internal Medicine
  • State License โ€“ New York: Full License # 285166
  • DEA Registration โ€“ FG6123385
  • Advanced Cardiac Life Support (ACLS) โ€“ Re-Certified on 10/09/2021

๐ŸŒ Professional Memberships

  • ๐Ÿ‘จโ€โš•๏ธ Member, American College of Physicians
  • ๐Ÿ‡ฎ๐Ÿ‡ณ Life Member, Gujarat Medical Council
  • ๐Ÿฉบ Member, American Medical Association (AMA)
  • ๐Ÿงฌ Member, American Society of Clinical Oncology (ASCO)
  • ๐ŸŒ Member, European Society for Medical Oncology (ESMO)
  • ๐Ÿฉธ Member, American Society of Hematology (ASH)

๐Ÿ”ฌ Research and Academic Work

Assistant Professor of Medicine & Clinical Investigator
SUNY Upstate Medical University (07/2016 โ€“ 06/2021)

  • Key Research Projects
    • ๐Ÿงฌ HPV-Positive Clinically Advanced Bladder Squamous Cell Carcinoma (aBSCC): Analyzed genomic alterations associated with HPV.
    • ๐Ÿง‘โ€๐Ÿ”ฌ Metabolic Syndrome & Immunotherapy in NSCLC: Studied the impact of metabolic syndrome on outcomes with immune checkpoint inhibitors in non-small cell lung cancer (NSCLC).
    • ๐Ÿฉธ Peripheral Blood Biomarkers in Metastatic Melanoma: Identified biomarkers for treatment response and immune-related adverse events in patients treated with immunotherapy for stage-IV melanoma.

๐Ÿ… Awards

  • Ranked in the top 10% of the class during medical school. ๐ŸŽ–๏ธ

Dr. Ghanshyam Ghelani is a dedicated Hematology-Oncology fellow with expertise in internal medicine and a strong background in cancer research, particularly in genomic profiling, immunotherapy, and biomarker discovery. ๐Ÿงฌ๐Ÿ’ก

 

๐Ÿ” Conclusion

Dr. Ghanshyam Ghelani is a highly accomplished medical professional, currently advancing his expertise as a Hematology-Oncology Fellow at SUNY Upstate Medical University. With a strong foundation in internal medicine and an impressive portfolio of research in cancer treatment and immunotherapy, Dr. Ghelani has made significant contributions to the field of oncology. His active involvement in professional societies and dedication to exploring novel cancer therapies highlight his commitment to improving patient outcomes through cutting-edge research and clinical practice. Dr. Ghelani’s journey reflects a deep passion for medicine, research, and innovation in cancer care. ๐Ÿ’‰๐Ÿงฌ๐ŸŒŸ

 

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

    • Radioimmunoconjugates in the Age of Modern Immuno-Oncology
      • Authors: Nasr, D., Kumar, P.A., Zerdan, M.B., Graziano, S., Lim, S.H.
      • Journal: Life Sciences
      • Year: 2022

     

    • HPV-Positive Clinically Advanced Squamous Cell Carcinoma of the Urinary Bladder (aBSCC): A Comprehensive Genomic Profiling (CGP) Study
      • Authors: Ghelani, G.H., Zerdan, M.B., Jacob, J., Bratslavsky, G., Basnet, A.
      • Journal: Urologic Oncology: Seminars and Original Investigations
      • Year: 2023

     

    • Breast Cancer Treatment: To Target or Not? That Is the Question
      • Authors: Stone, A., Lin, K.M., Ghelani, G.H., Graziano, S., Kotula, L.
      • Journal: Cancers
      • Year: 2023

     

    • Hematologic Abnormalities After COVID-19 Infection: A Case of Coombs-Negative Hemolytic Anemia and Thrombocytopenia
      • Authors: Siegenthaler, A.G., Ghelani, G., Brady, A., Loon, T., Madhira, B.R.
      • Journal: Journal of Investigative Medicine High Impact Case Reports
      • Year: 2023

     

    • Metabolic Syndrome Is Independently Associated with Improved Overall Survival to First-Line Therapy with Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
      • Authors: Bou Zerdan, M., Ashok Kumar, P., Barrios, D.M., Graziano, S., Lim, S.H.
      • Journal: Frontiers in Oncology
      • Year: 2023